These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 38283636)

  • 21. Factors associated with critical care requirements in diabetic patients treated with dexamethasone for COVID-19 infection in the first wave of the pandemia.
    Batule S; Soldevila B; Figueredo C; Julián MT; Egea-Cortés L; Reyes-Ureña J; Casabona J; Mateu L; Paredes R; Clotet B; López R; Puig-Domingo M; Alonso N
    Front Endocrinol (Lausanne); 2022; 13():1009028. PubMed ID: 36619546
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glycated hemoglobin level dynamics in COVID-19 survivors: 12 months follow-up study after discharge from hospital.
    Shestakova M; Kononenko I; Kalmykovа Z; Markova T; Kaplun E; Lysenko M; Mokrysheva N
    PLoS One; 2022; 17(11):e0275381. PubMed ID: 36350895
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Profile and prognosis of patients hospitalized for COVID-19 virus infection with and without diabetes - An observational study from South India.
    Raghavan A; Nanditha A; Satheesh K; Susairaj P; Vinitha R; Chandrasekaran S; Palaniappan T; Thillai Vallal S; Subair Khan A; Snehalatha C; Ramachandran A
    Diabetes Metab Syndr; 2021; 15(4):102143. PubMed ID: 34186345
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glycemic Gap Predicts Mortality in a Large Multicenter Cohort Hospitalized With COVID-19.
    McDonnell ME; Garg R; Gopalakrishnan G; Mitri J; Weinstock RS; Greenfield M; Katta S; Lebastchi J; Palermo NE; Radhakrishnan R; Westcott GP; Johnson M; Simonson DC
    J Clin Endocrinol Metab; 2023 Feb; 108(3):718-725. PubMed ID: 36217580
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sleeping disturbances and predictor risk factors among type 2 diabetic mellitus patients.
    Bener A; Al-Hamaq AOAA; Agan AF; Öztürk M; Ömer A
    Ann Afr Med; 2020; 19(4):230-236. PubMed ID: 33243945
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of SARS-CoV-2 Infection and Infection Severity on Longer-Term Glycemic Control and Weight in People With Type 2 Diabetes.
    Wong R; Vaddavalli R; Hall MA; Patel MV; Bramante CT; Casarighi E; Johnson SG; Lingam V; Miller JD; Reusch J; Saltz M; Stürmer T; Tronieri JS; Wilkins KJ; Buse JB; Saltz J; Huling JD; Moffitt R;
    Diabetes Care; 2022 Nov; 45(11):2709-2717. PubMed ID: 36098660
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Should We Be Concerned about the Association of Diabetes Mellitus and Periodontal Disease in the Risk of Infection by SARS-CoV-2? A Systematic Review and Hypothesis.
    Casillas Santana MA; Arreguín Cano JA; Dib Kanán A; Dipp Velázquez FA; Munguía PDCS; Martínez Castañón GA; Castillo Silva BE; Sámano Valencia C; Salas Orozco MF
    Medicina (Kaunas); 2021 May; 57(5):. PubMed ID: 34068221
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical Features and Changes in Insulin Requirements in People with Type 2 Diabetes Requiring Insulin When Hospitalised with SARS-CoV-2 Infection.
    Corcillo A; Saqib A; Sithamparanathan N; Khanam A; Williams J; Gulati A; Kariyawasam D; Karalliedde J
    Int J Endocrinol; 2022; 2022():8030765. PubMed ID: 35256883
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antidiabetic Treatment before Hospitalization and Admission Parameters in Patients with Type 2 Diabetes, Obesity, and SARS-CoV-2 Viral Infection.
    Reștea PA; Mureșan M; Voicu A; Jurca T; Pallag A; Marian E; Vicaș LG; Jeican II; Crivii CB
    J Pers Med; 2023 Feb; 13(3):. PubMed ID: 36983573
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ivermectin for preventing and treating COVID-19.
    Popp M; Stegemann M; Metzendorf MI; Gould S; Kranke P; Meybohm P; Skoetz N; Weibel S
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD015017. PubMed ID: 34318930
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors for COVID-19 case fatality rate in people with type 1 and type 2 diabetes mellitus: A nationwide retrospective cohort study of 235,248 patients in the Russian Federation.
    Shestakova MV; Vikulova OK; Elfimova AR; Deviatkin AA; Dedov II; Mokrysheva NG
    Front Endocrinol (Lausanne); 2022; 13():909874. PubMed ID: 36017317
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors associated with clinical severity in emergency department patients presenting with symptomatic SARS-CoV-2 infection.
    Newton S; Zollinger B; Freeman J; Moran S; Helfand A; Authelet K; McHarg M; Montano Vargas N; Shesser R; Cohen JS; Cummings DAT; Ma Y; Meltzer AC
    J Am Coll Emerg Physicians Open; 2021 Aug; 2(4):e12453. PubMed ID: 34223443
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mortality in People with Type 2 Diabetes Following SARS-CoV-2 Infection: A Population Level Analysis of Potential Risk Factors.
    Heald AH; Jenkins DA; Williams R; Sperrin M; Mudaliar RN; Syed A; Naseem A; Bowden Davies KA; Peng Y; Peek N; Ollier W; Anderson SG; Delanerolle G; Gibson JM
    Diabetes Ther; 2022 May; 13(5):1037-1051. PubMed ID: 35416588
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Newly-diagnosed diabetes and admission hyperglycemia predict COVID-19 severity by aggravating respiratory deterioration.
    Fadini GP; Morieri ML; Boscari F; Fioretto P; Maran A; Busetto L; Bonora BM; Selmin E; Arcidiacono G; Pinelli S; Farnia F; Falaguasta D; Russo L; Voltan G; Mazzocut S; Costantini G; Ghirardini F; Tresso S; Cattelan AM; Vianello A; Avogaro A; Vettor R
    Diabetes Res Clin Pract; 2020 Oct; 168():108374. PubMed ID: 32805345
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Severe Acute Respiratory Syndrome by SARS-CoV-2 Infection or Other Etiologic Agents Among Brazilian Indigenous Population: An Observational Study from the First Year of Coronavirus Disease (COVID)-19 Pandemic.
    Sansone NMS; Boschiero MN; Ortega MM; Ribeiro IA; Peixoto AO; Mendes RT; Marson FAL
    Lancet Reg Health Am; 2022 Apr; 8():100177. PubMed ID: 35018359
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glycemic and lipid profile of patients with COVID-19: Impact on morbidity and mortality.
    Armonis C; Komnianou K; Grigoropoulou P; Fragkou A; Kyritsi E; Tousoulis D; Toutouzas K
    Clin Nutr ESPEN; 2023 Dec; 58():362-367. PubMed ID: 38057028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and Epidemiological Features of SARS-CoV-2 Patients in SARI Ward of a Tertiary Care Centre in New Delhi.
    Aggarwal A; Shrivastava A; Kumar A; Ali A
    J Assoc Physicians India; 2020 Jul; 68(7):19-26. PubMed ID: 32602676
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hydroxychloroquine in the treatment of adult patients with Covid-19 infection in a primary care setting (LIBERTY): A structured summary of a study protocol for a randomised controlled trial.
    Vainio PJ; Hietasalo P; Koivisto AL; Kääriäinen S; Turunen J; Virtala M; Vuorinen J; Scheinin M
    Trials; 2021 Jan; 22(1):44. PubMed ID: 33430933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.